Accent Microcell (NSE:ACCENTMIC) EBIT: ₹440 Mil (TTM As of Mar. 2025)


NSE:ACCENTMIC Accent Microcell Ltd NSE:ACCENTMIC
19 GF Score
Price ₹483.70
! 6 Warning Signs
View Full Analysis

What is Accent Microcell EBIT?

Accent Microcell NSE:ACCENTMIC +5.23% 19 EBIT is ₹440 Mil as of Mar. 2025. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 19/100. The stock has 6 warning signs investors should review.

Accent Microcell's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2025 was ₹440 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹440 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Accent Microcell's annualized ROC % for the quarter that ended in Mar. 2025 was 21.63%. Accent Microcell's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 35.74%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Accent Microcell's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 4.29%.

Accent Microcell  (NSE:ACCENTMIC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Accent Microcell's annualized ROC % for the quarter that ended in Mar. 2025 is calculated as:

ROC % (Q: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Mar. 2025 ))/ count )
=385.489 * ( 1 - 24.44% )/( (1118.526 + 1575.205)/ 2 )
=291.2754884/1346.8655
=21.63 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2048.397 - 206.431 - ( 723.44 - max(0, 378.58 - 1634.42+723.44))
=1118.526

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2283.744 - 198.405 - ( 510.134 - max(0, 303.931 - 1543.554+510.134))
=1575.205

Note: The Operating Income data used here is one times the annual (Mar. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Accent Microcell's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Mar. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=440.432/( ( (399.097 + max(624.944, 0)) + (724.426 + max(716.121, 0)) )/ 2 )
=440.432/( ( 1024.041 + 1440.547 )/ 2 )
=440.432/1232.294
=35.74 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(538.042 + 329.832 + 22.722) - (206.431 + 0 + 59.221)
=624.944

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(648.761 + 336.251 + 28.512) - (198.405 + 0 + 98.998)
=716.121

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Accent Microcell's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2025 )
=440.432/10265.479
=4.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accent Microcell EBIT Related Terms

Accent Microcell EBIT Historical Data

* Premium members only.

The historical data trend for Accent Microcell's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accent Microcell EBIT Chart

Accent Microcell Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
EBIT
89.12 103.64 169.38 375.23 440.43

Accent Microcell Semi-Annual Data
Mar21 Mar22 Mar23 Mar24 Mar25
EBIT 89.12 103.64 169.38 375.23 440.43

NSE:ACCENTMIC vs ZTS, UTHR: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accent Microcell EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Accent Microcell's EV-to-EBIT falls into.


NSE:ACCENTMIC
19GF Score
Accent Microcell Ltd NSE:ACCENTMIC
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accent Microcell EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹440 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹440 Mil mean?
Accent Microcell (NSE:ACCENTMIC) has a EBIT of ₹440 Mil as of Mar. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Accent Microcell.
Is Accent Microcell's EBIT too high?
Accent Microcell's current EBIT is ₹440 Mil. Overall, Accent Microcell has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's EBIT compare to ZTS and UTHR?
Accent Microcell's EBIT of ₹440 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Accent Microcell. Accent Microcell's current EBIT is ₹440 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current EBIT of ₹440 Mil. The current EBIT is ₹440 Mil. Accent Microcell's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current EBIT is ₹440 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accent Microcell Business Description

Address Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
19GF Score

Get the complete analysis for NSE:ACCENTMIC

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹483.70
Price